Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05294939
Other study ID # UCAMCFE-00022
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 31, 2022
Est. completion date March 28, 2022

Study information

Verified date November 2021
Source Universidad Católica San Antonio de Murcia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized, controlled, double-blind, crossover clinical trial, depending on the product consumed, to analyze the efficacy on physical performance of a sports supplement consumed prior to and during competition or training.


Description:

Subjects who meet the selection criteria will be randomly assigned to each of the study groups (investigational product or placebo, depending on the group to which they have been assigned). On the second day, participants will consume the product that subjects did not consume on the first day. The product to be consumed will be ketone monoester. Participants will consume 800 mg/kg body weight, distributed in two intakes. The first one, half an hour before exercise and the same dose will be consumed one hour and a half after the first dose. The intakes will be accompanied by carbohydrates and bicarbonate. The tests that the cyclists will perform are a time trial on a cycloergometer to measure performance, as well as a 30" sprint. Afterwards, the cyclists will do a 4 and a half hour training session at competition pace. After this training session, the participants will do the same time trial and the 30'' sprint.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date March 28, 2022
Est. primary completion date February 5, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Male professional cyclists. - Start the study with previous rest. Exclusion Criteria: - Participant suffering from chronic illness. - Suffering a long-term injury that prevents her from training in the month prior to the intervention. - Inability to understand the informed consent. - Having consumed ketone bodies chronically in the previous four weeks. - To have undergone cholecystectomy.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Ketone monoester
Consumption of 800mg/kg body weight of ketone monoester, divided in two intakes. The mixture will be prepared with bicarbonate. In addition, every hour they should consume 90g of carbohydrates.
Control product consumption
Consumption of placebo product (carbohydrates) masked with citric, divided in two intakes. The mixture will be prepared with bicarbonate. In addition, 90g of carbohydrates should be consumed every hour.

Locations

Country Name City State
Spain Catholic University of Murcia Murcia

Sponsors (1)

Lead Sponsor Collaborator
Universidad Católica San Antonio de Murcia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical performance Measured using a power roller. Variables such as maximum power and average power Change in performance after product consumption and training at a competitive level
Secondary Heart Rate Measured by a chest strap It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
Secondary Microcapillary blood This test provides biochemical variables (ABL90FLEX) with 70 ml of capillary blood. It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
Secondary Lactate Lactate levels will be measured using the Lactate Pro It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
Secondary Ketone Will be measured by the FreeStyle Optium It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
Secondary Blood glucose Will be measured by the FreeStyle Optium It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
Secondary Blood glucose It will be measured continuously by Supersapiens. It will be measured on a daily basis. Measurements will begin two days before the first performance test and end one day after the completion of the performance tests.
Secondary Heart rate variability It will be measured for 5 minutes upon awakening. It will be measured every morning. Measurements will be started two days before the first performance test and finished one day after the end of the performance tests.
Secondary Stomach test It will be measured by means of a visual analog scale from 0 to 10 to determine the annoyance produced by the product (0: none and 10: maximum annoyance). It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
Secondary Fatigue Rate of perceived exertion It will be measured on four different occasions. Two on the first day (after one intake of product and after a second intake and training at competitive pace) and 4 days later, the same measurements but with the opposite product.
See also
  Status Clinical Trial Phase
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04817176 - MI-CBT Adherence Program for Lifestyle Interventions in Older Adults Early Phase 1
Completed NCT04565444 - Ketones and Muscle Protein Synthesis N/A
Not yet recruiting NCT06418074 - Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity N/A
Not yet recruiting NCT03954665 - Ketone Supplementation and Exercise Performance N/A
Active, not recruiting NCT06097754 - Intermittent Exogenous Ketosis (IEK) at High Altitude N/A
Terminated NCT03790436 - Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet N/A
Completed NCT03299543 - Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate
Recruiting NCT04004676 - Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise N/A
Not yet recruiting NCT03659825 - Ketone Esters for Optimization of Cognitive Performance in Hypoxia N/A
Active, not recruiting NCT04156477 - Markers of Appetite Regulation During Exogenous Ketosis N/A
Completed NCT04130724 - Characterization of a Portable Solid-State Breath Acetone Testing Device for Real-Time Ketosis Status
Recruiting NCT04594265 - Weight-Adjusted Dosing of 3-OHB in Patients With Chronic Heart Failure Phase 2
Not yet recruiting NCT04576026 - Exogenous Ketone Supplementation and Cognitive Function During Exercise N/A
Completed NCT05558488 - The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response N/A
Recruiting NCT03564002 - Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
Completed NCT04309214 - Market Research - Acceptability Study for New MCT Fat Products N/A
Completed NCT05588427 - Effect of Ketone Ester Supplementation on Hypoxic Tolerance N/A
Recruiting NCT05656339 - Metabolic Effects of Whey Protein Supplementation After Fasting in Volunteers N/A